NASDAQ · NAKA
Healthcare · Medical - Equipment & Services
$7.36
Down-$0.33 (-4.29%)
Updated Oct 24, 2026, 3:58 PM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · NAKA
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 23, 2026
NAKA closed at $7.36 after 21 trading sessions, down 26.33% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | $7.70 | $7.87 | $7.31 | $7.36 | 122.99K |
| Oct 22, 2026 | $7.98 | $8.2699 | $7.2592 | $7.69 | 281.41K |
| Oct 21, 2026 | $7.36 | $8.73 | $7.36 | $8.445 | 335.68K |
| Oct 20, 2026 | $7.08 | $7.77 | $6.96 | $7.14 | 218.08K |
| Oct 19, 2026 | $7.23 | $7.635 | $7.01 | $7.23 | 206.59K |
| Oct 16, 2026 | $8.00 | $8.11 | $7.08 | $7.13 | 170.64K |
| Oct 15, 2026 | $7.77 | $8.18 | $7.6101 | $8.09 | 116.72K |
| Oct 14, 2026 | $8.34 | $8.44 | $7.90 | $7.96 | 176.59K |
| Oct 13, 2026 | $8.22 | $8.6525 | $8.19 | $8.58 | 69.36K |
| Oct 12, 2026 | $8.54 | $8.83 | $8.14 | $8.26 | 150.26K |
| Oct 9, 2026 | $9.07 | $9.0896 | $8.46 | $8.54 | 200.06K |
| Oct 8, 2026 | $9.25 | $9.7417 | $8.8216 | $8.93 | 181.65K |
| Oct 7, 2026 | $9.20 | $9.71 | $9.16 | $9.34 | 120.81K |
| Oct 6, 2026 | $10.18 | $10.3162 | $9.45 | $9.57 | 133.98K |
| Oct 5, 2026 | $9.82 | $10.525 | $9.44 | $10.05 | 289.35K |
| Oct 2, 2026 | $9.51 | $10.345 | $9.42 | $9.66 | 362.28K |
| Oct 1, 2026 | $9.44 | $9.63 | $9.08 | $9.11 | 143.01K |
| Sep 30, 2026 | $9.98 | $10.12 | $9.42 | $9.46 | 107.51K |
| Sep 29, 2026 | $9.89 | $9.98 | $9.645 | $9.76 | 120.98K |
| Sep 28, 2026 | $9.95 | $10.08 | $9.51 | $9.72 | 132.97K |
| Sep 25, 2026 | $9.86 | $10.11 | $9.41 | $9.99 | 183.81K |
The latest Smart Investors Daily articles mentioning NAKA.
Company
Market Activity
Research & News
NAKA research
Company profile and research snapshot.
Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 22, 2026 | B. Riley Securities | Buy | — |
| Sep 3, 2026 | B. Riley Securities | Buy | — |
| Jul 27, 2026 | TD Cowen | Buy | — |
| Apr 10, 2026 | TD Cowen | Buy | — |
| Apr 6, 2026 | Maxim Group | Buy | — |
No generated briefing is available yet.
Benzinga · Oct 8, 2026
Gainers Profound Medical (NASDAQ:PROF) shares moved upwards by 21.5% to $6.9 during Thursday's pre-market session. The company's market cap stands at $207.5 million. Haemonetics (NYSE:HAE) stock moved upwards
Benzinga · Oct 6, 2026
Bitcoin may reach $132,750 by 2027 and $275,000 by 2029; well-run BTC treasury firms could outperform Bitcoin by ~50%.
Benzinga · Sep 22, 2026
B. Riley Securities analyst Fedor Shabalin maintains Nakamoto (NASDAQ:NAKA) with a Buy and raises the price target from $11 to $13.
Benzinga · Sep 3, 2026
B. Riley Securities analyst Fedor Shabalin maintains Nakamoto (NASDAQ:NAKA) with a Buy and raises the price target from $9 to $11.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning NAKA.
